Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroectodermal Tumors × Radiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 221 Breast Neoplasms 195 Lung Neoplasms 184 Glioblastoma 179 Head and Neck Neoplasms 168 Prostatic Neoplasms 152 Squamous Cell Carcinoma of Head and Neck 138 Lymphoma 137 Rectal Neoplasms 123 Central Nervous System Neoplasms 107 Esophageal Neoplasms 103 Leukemia 97 Brain Neoplasms 92 Pancreatic Neoplasms 86 Precursor Cell Lymphoblastic Leukemia-Lymphoma 83 Gliosarcoma 81 Esophageal Squamous Cell Carcinoma 71 Lymphoma, Follicular 70 Uterine Cervical Neoplasms 69 Neoplasms 69 Lymphoma, Large B-Cell, Diffuse 69 Lymphoma, Non-Hodgkin 66 Hodgkin Disease 66 Sarcoma 65 Burkitt Lymphoma 60 Glioma 59 Colorectal Neoplasms 58 Leukemia, Lymphocytic, Chronic, B-Cell 56 Astrocytoma 54 Lymphoma, Large-Cell, Immunoblastic 52

Interventions

Vincristine 2 Temozolomide 2 vorasidenib 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 pamiparib 1 lutetium Lu 177 dotatate 1 copper dotatate CU-64 1 cixutumumab 1 Vorinostat 1 Valproic Acid 1 Thiotepa 1 Sunitinib 1 Radiotherapy 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 Oncolytic Virotherapy 1 ONC206 1 Melphalan 1 Maintenance Chemotherapy 1 Lutetium-177 1 Lutetium 1 Lomustine 1 Interleukin-12 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Erlotinib Hydrochloride 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01614132 2020-03-31

NOA-07

University of Regensburg

Phase 1/2 Completed

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡